| Price and Volume | |
|---|---|
| Recent Price | 13.78 |
| 52 Week High | 21.00 |
| 52 Week Low | 10.15 |
| Avg. Daily Vol. (Mil) | 0.42 |
| Beta (3 year) | 1.59 |
| Share Related Items | |
| Mkt Cap (Mil) | 709.94 |
| Shares Out (Mil) | 51.52 |
| Float (Mil) | 50.04 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 17.00 |
| Current Ratio | 18.80 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 6.00 |
| Price/Sales | 3.10 |
| Price/Book | 1.77 |
| Price/Cash Flow | 5.60 |
| Per Share Data | |
| Earnings | 2.31 |
| Sales | 4.45 |
| Book Value | 7.81 |
| Cash Flow | 2.45 |
| Business Summary | |
|---|---|
| Momenta Pharmaceuticals, Inc. is a biotechnology company with a product pipeline of both complex mixture generic and novel drugs. | |
| General Information | |
| 675 West Kendall Street
Cambridge, MA 02142 |
|
| www.momentapharma.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 197 | |
| CEO: Craig A. Wheeler | |
| Short Interest | |
| Current Month (Mil) | 6.81 |
| Previous Month (Mil) | 6.72 |
| Short Interest Ratio (Days) | 19.60 |
| Management Effectiveness | |
| Return on Equity | 29.40 |
| Return on Assets | 26.00 |
| Return on Investments | 29.40 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | 51.70 |
| Profit Margin | 51.70 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
106.76
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet